COLORECTAL CANCER, SUSCEPTIBILITY TO, 12
|
disease |
|
Finding
|
165
|
368
|
0.100 |
None |
1.000 |
5 |
2
|
2014 |
2019 |
Malignant neoplasm of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
165
|
368
|
0.100 |
None |
1.000 |
5 |
2
|
2014 |
2019 |
Adenocarcinoma of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
165
|
368
|
0.100 |
None |
1.000 |
5 |
2
|
2014 |
2019 |
COLORECTAL CANCER, SUSCEPTIBILITY TO, 1
|
disease |
|
Finding
|
165
|
368
|
0.100 |
None |
1.000 |
5 |
2
|
2014 |
2019 |
Colorectal Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
165
|
368
|
0.100 |
None |
1.000 |
5 |
2
|
2014 |
2019 |
Colorectal Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
165
|
368
|
0.100 |
None |
1.000 |
5 |
2
|
2014 |
2019 |
COLORECTAL CANCER, SUSCEPTIBILITY TO, 10
|
disease |
|
Finding
|
165
|
368
|
0.100 |
None |
1.000 |
5 |
2
|
2014 |
2019 |
COLORECTAL CANCER, SUSCEPTIBILITY TO, 3
|
phenotype |
|
Finding
|
165
|
368
|
0.100 |
None |
1.000 |
5 |
2
|
2014 |
2019 |
Malignant tumor of colon
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
165
|
368
|
0.100 |
None |
1.000 |
5 |
2
|
2014 |
2019 |
Triglycerides measurement
|
phenotype |
|
Laboratory Procedure
|
324
|
837
|
0.100 |
None |
1.000 |
4 |
2
|
2008 |
2019 |
Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
295
|
731
|
0.100 |
None |
1.000 |
4 |
2
|
2012 |
2019 |
High density lipoprotein measurement
|
phenotype |
|
Laboratory Procedure
|
353
|
951
|
0.100 |
None |
1.000 |
3 |
2
|
2012 |
2018 |
Crohn Disease
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
239
|
616
|
0.100 |
None |
1.000 |
2 |
2
|
2015 |
2016 |
Red Blood Cell Count measurement
|
phenotype |
|
Laboratory Procedure
|
685
|
1141
|
0.100 |
None |
1.000 |
2 |
2
|
2016 |
2018 |
Serum total cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
308
|
766
|
0.100 |
None |
1.000 |
2 |
2
|
2012 |
2018 |
RESTING HEART RATE
|
phenotype |
|
Finding
|
80
|
128
|
0.100 |
None |
1.000 |
2 |
1
|
2016 |
2018 |
Chronic Kidney Diseases
|
group |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
35
|
97
|
0.100 |
None |
1.000 |
1 |
6
|
2018 |
2018 |
Psoriasis
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
237
|
485
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Arachidonic acid measurement
|
phenotype |
|
Laboratory Procedure
|
4
|
4
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Ulcerative Colitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
211
|
464
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Cholangitis, Sclerosing
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
149
|
276
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Moyamoya disease 1
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
19
|
30
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Blood Protein Measurement
|
phenotype |
|
Laboratory Procedure
|
1156
|
2575
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Adenoma of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
65
|
114
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Iron binding capacity total measurement
|
phenotype |
|
Laboratory Procedure
|
20
|
35
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |